Darzalex (daratumumab) supply for hospitals & distributors
Anti-CD38 monoclonal antibody · Janssen (Johnson & Johnson Innovative Medicine)
Darzalex (daratumumab) is Janssen's anti-CD38 monoclonal antibody, a backbone of modern multiple myeloma regimens. It is available as an intravenous concentrate and as a fixed-dose subcutaneous injection (co-formulated with hyaluronidase).
Prescription-only medicine. No prices are published. Supply is to hospitals, distributors, pharmacies and physicians against a valid prescription or purchase order. This page is product information, not medical advice.
Product facts
Strengths and presentation
- 1800 mg/15 mL solution for subcutaneous injection (Darzalex SC / Faspro)
- 100 mg/5 mL and 400 mg/20 mL concentrate for IV infusion
Approved indications (EMA / FDA label summary)
- Newly diagnosed multiple myeloma, in combination regimens (transplant-eligible and ineligible)
- Relapsed or refractory multiple myeloma, alone or in combination
- Newly diagnosed systemic AL amyloidosis (subcutaneous formulation, with bortezomib, cyclophosphamide and dexamethasone)
Short label summary only. Approved indications differ by country and line of therapy; the national label in the destination country governs.
Storage and cold chain
- Store refrigerated at 2–8 °C in the original carton to protect from light
- Do not freeze; do not shake
- Shipped in validated cold-chain packaging with temperature data logging
How we supply
- Original manufacturer packs only — sourced from licensed wholesalers in Türkiye and Europe, never repackaged or relabelled.
- Batch number and expiry confirmed in writing before dispatch; every pack is traceable to its batch.
- Documents with every consignment: commercial invoice, batch / CoA information from the source, and packing list.
- Validated 2–8 °C cold-chain shipping with a temperature data logger from origin to handover.
- Named-patient and special-import support: we prepare the paperwork your hospital or importer needs for the local regulator.
Procurement notes
Many centres have moved to the 1800 mg subcutaneous vial, which simplifies ordering to one vial per administration. Please state whether you need the SC or the IV presentation — they are not interchangeable on an order.
Who we supply
- Hospital pharmacy and procurement departments
- Licensed pharmaceutical distributors and importers
- Oncology and haematology centres
- Treating physicians arranging named-patient supply
Markets served
United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain and Iraq. Import into each country follows that country's regulator (for example MOHAP / DoH / DHA, SFDA, MoPH, Kuwait MOH, Oman MOH, NHRA) — we work with the receiving institution's import route.
Frequently asked questions
Do you supply Darzalex subcutaneous or intravenous?
Both presentations can be sourced. The 1800 mg/15 mL subcutaneous vial is the most frequently requested; IV 100 mg and 400 mg vials are quoted on request.
Can Darzalex be supplied with other myeloma medicines?
Yes. Combination partners such as lenalidomide (Revlimid) or bortezomib can be quoted in the same enquiry, each with separate batch documents.
Is the Darzalex you supply an original manufacturer pack?
Yes. We supply Darzalex only in the original Janssen (Johnson & Johnson Innovative Medicine) pack, sourced from licensed wholesalers in Türkiye and Europe, never repackaged or relabelled.
Which documents come with a consignment?
Commercial invoice, batch / CoA information from the source and a packing list, with batch number and expiry for every pack. Additional documents requested by your importer can be prepared.
Do you supply the UAE, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain and Iraq?
Yes — to hospitals, distributors and licensed centres in these countries, through the import or named-patient route accepted by the destination country's regulator.
How do I get a quote for Darzalex?
Send a supply inquiry on WhatsApp with strength, quantity, country and institution. We reply with a written quote, availability and expiry; we do not publish prices on the site.
Send a supply inquiry
Tell us the product, strength, quantity, destination country and the receiving institution. We reply with availability, batch/expiry and the documentation set — and a written quote. We do not sell to the public.
Send a supply inquiryOther medicines we supply to the Gulf
- Keytruda (pembrolizumab)
- Opdivo (nivolumab)
- Enhertu (trastuzumab deruxtecan)
- Tagrisso (osimertinib)
- Imfinzi (durvalumab)
- Tecentriq (atezolizumab)
- Perjeta (pertuzumab)
- Kadcyla (trastuzumab emtansine)
- Lynparza (olaparib)
- Revlimid (lenalidomide)
- Imbruvica (ibrutinib)
- Venclyxto (venetoclax)
- Xtandi (enzalutamide)
- Adcetris (brentuximab vedotin)
Sources
Reviewed by Pharmacy Remedy Pharmacovigilance & Compliance Desk · Last updated: 2026-11-04